# OnCo record paper-classic-5-year-follow-up-noh-lancet-oncol-2014 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-classic-5-year-follow-up-noh-lancet-oncol-2014/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-classic-5-year-follow-up-noh-lancet-oncol-2014" ;
  schema:name "CLASSIC 5-year follow-up: adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy"@en ;
  schema:description "Five years on, the benefit of adjuvant capecitabine and oxaliplatin held and translated into longer survival: 78 percent alive against 69 percent with surgery alone."@en ;
  schema:url <https://onco.cc/key-papers/paper-classic-5-year-follow-up-noh-lancet-oncol-2014/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(14)70473-5>, <https://pubmed.ncbi.nlm.nih.gov/25439693/> ;
  schema:sameAs <https://doi.org/10.1016/S1470-2045(14)70473-5> ;
  schema:datePublished "2014"^^xsd:gYear ;
  schema:author "Noh SH, Park SR, Yang HK, et al." ;
  onco:cancers <https://onco.cc/cancers/gastric/> ;
  onco:drugs <https://onco.cc/drugs/capecitabine/>, <https://onco.cc/drugs/oxaliplatin/> ;
  onco:trials <https://onco.cc/trials/classic/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .